Guardian Partners Inc. Novartis Ag Transaction History
Guardian Partners Inc.
- $983 Billion
- Q4 2024
A detailed history of Guardian Partners Inc. transactions in Novartis Ag stock. As of the latest transaction made, Guardian Partners Inc. holds 2,175 shares of NVS stock, worth $234,356. This represents 0.02% of its overall portfolio holdings.
Number of Shares
2,175Holding current value
$234,356% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding NVS
# of Institutions
1,444Shares Held
132MCall Options Held
1.12MPut Options Held
1.61M-
Dodge & Cox San Francisco, CA12.2MShares$1.32 Billion0.85% of portfolio
-
Primecap Management CO Pasadena, CA11MShares$1.19 Billion0.85% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.09MShares$872 Million0.23% of portfolio
-
Morgan Stanley New York, NY6.98MShares$753 Million0.06% of portfolio
-
Loomis Sayles & CO L P5.77MShares$622 Million0.87% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $232B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...